New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 25, 2014
10:06 EDTDVA, FMSMedicare urged by auditor to recalculate dialysis payments
An updated report released by the Health and Human Services Departmentís Inspector General recommended that the Centers for Medicare & Medicaid Services redetermine the basis of the end stage renal disease, or ESRD, base rate to reflect current trends in drug acquisition costs, as required by law; distinguish payments in the ESRD base rate between independent and hospital-based dialysis facilities; and consider updating the ESRD payment bundle using a factor that takes into account drug acquisition costs. "CMS did not explicitly state whether it concurred with our first recommendation, did not concur with our second recommendation, and concurred with our third recommendation," the report stated. DaVita (DVA) and Fresenius Medical (FMS) are publicly-traded companies that operate dialysis centers. Reference Link
News For DVA;FMS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 22, 2014
20:03 EDTDVADaVita Kidney Care finalizes DOJ Settlement
DaVita Kidney Care, a division of DaVita HealthCare Partners announced it has finalized its comprehensive settlement with the U.S. Department of Justice, or DOJ, and certain other federal agencies regarding allegations of improperly structured joint ventures with certain physician partners. As announced in February, DaVita Kidney Care will be subject to a Corporate Integrity Agreement and an independent monitor to oversee certain future joint ventures. The agreement also includes a repayment to the government and a provision requiring executive certification of quarterly and annual compliance reports.
13:35 EDTFMSFresenius Medical acquires National Cardiovascular Partners
Fresenius Medical Care announced the acquisition of National Cardiovascular Partners, or NCP. The parties involved agreed not to disclose the financial terms of the acquisition. The company expects NCP to generate in excess of $200M in revenue in 2015 and expects the investment to be accretive to earnings in the first year after closing. The investment will be financed through available cash and committed credit facilities, supplemented by additional debt financing. NCP is the leading operator of endovascular, vascular and cardiovascular services in the comfort and convenience of the outpatient setting. In partnership with over 200 physicians, NCP operates 21 outpatient vascular centers in six states.
06:42 EDTDVADaVita to acquire CSHP
Subscribe for More Information
October 19, 2014
14:18 EDTFMSFresenius, others explore bid for Danone medical nutrition unit, Reuters says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use